CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Developmental Serum +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03640832
NCT03640832N/ACompleted
CompareCT.gov

A Clinical Study to Assess the Local Cutaneous and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin

GlaxoSmithKline·interventional·Posted Aug 21, 2018·Updated Nov 27, 2020

In Brief

A clinical study evaluating Developmental Serum and Physiogel Calming Relief Anti-Redness Serum for Skin Care. Completed, enrolled 90 participants across 1 site.

Detailed Summary

To determine the local cutaneous and ocular tolerance of a developmental cosmetic facial serum in healthy females with sensitive facial skin under normal conditions of use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Care
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 21, 2018
Enrollment StartOct 15, 2018
Primary CompletionNov 13, 2018
TodayJul 2, 2026
Enrollment to primary: 28 daysPosted 7.9 years ago

Interventions

Developmental Serumother

A 30millilitre (mL) bottle with a piston pump will be dispensed to the participants, to be used as a topical dermal (facial) application, twice daily as per normal home use.

Physiogel Calming Relief Anti-Redness Serumother

A 30mL bottle with a piston pump will be dispensed to the participants, to be used as a topical dermal (facial) application, twice daily as per normal home use.